The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A

BACKGROUND: Acquired haemophilia A (AHA) is a rare bleeding disorder caused by the development of specific autoantibodies against naturally occurring factor VIII (FVIII). Although about half of cases are idiopathic, AHA may be associated with several non-neoplastic conditions, autoimmune disorders,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Transfus
Egile Nagusiak: D’Arena, Giovanni, Grandone, Elvira, Di Minno, Matteo N.D., Musto, Pellegrino, Di Minno, Giovanni
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Edizioni SIMTI - SIMTI Servizi Srl 2016
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918557/
https://ncbi.nlm.nih.gov/pubmed/26509821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2015.0090-15
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak